Nemaura Medical Inc. (NMRD) Misses Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Nemaura Medical Inc. (NMRD) Misses Q2 EPS by 3c

Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update

August 15, 2022 8:30 AM EDT

Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (Nemaura or the Company), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today releases its financial results for the quarter ending June 30, 2022 and provides a business update.

Recent Corporate Highlights:

Company entered into a new note purchase agreement in May 2022 and received $5 million in proceeds

We are... More